查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1751207

美國醫藥開發外包市場規模、佔有率、趨勢分析報告：按服務、配方、治療領域、最終用途、地區、細分市場預測，2025-2030 年

U.S. Formulation Development Outsourcing Market Size, Share, & Trends Analysis Report By Service, By Formulation (Oral, Injectable), By Therapeutic Area (Oncology), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國配方開發外包市場規模將達到 88.7 億美元，2025 年至 2030 年的複合年成長率將達到 8.3%。

這一成長的驅動力源於對創新型醫藥和生物技術產品日益成長的需求、不斷上漲的研發成本以及對專業知識的需求。對於希望簡化研發流程、降低成本並取得更廣泛資源的公司而言，外包配方開發是個相當吸引人的選擇。

製藥和生技公司研發投入的激增是推動製劑開發外包服務需求成長的主要因素。過去二十年，研發支出和新藥上市數量不斷增加，透過外包可以節省成本並加快流程。這種日益成長的需求促使合約服務提供者拓展其能力，從而刺激了美國製劑開發外包產業的成長。因此，這些因素對市場擴張做出了重大貢獻。

藥物配方成本高、耗時耗力，嚴重依賴試驗來預測最佳配方。估算最佳配方對於滿足醫藥市場對新型活性藥物原料藥(API) 的需求以及降低整體醫療保健成本至關重要。這有助於業界找到高效的藥物開發方法。因此，製藥和生物技術行業廣泛將這些服務委託給契約製造製造商，以簡化成本和流程。

技術創新的動力促使企業投資發現新化合物和開發重磅藥物，導致學名藥製造商增加，並且由於用於治療未滿足的醫療需求和罕見疾病的藥物的研發活動不斷增加，醫藥市場也不斷擴大。

美國醫藥開發外包報告細分

該報告提供了2018年至2030年各國收益成長預測，並分析了各細分領域的最新產業趨勢。在本研究中，Grand View Research根據服務、配方、治療領域和最終用途對美國醫藥開發外包市場進行了細分：

  • 服務業展望（銷售額，2018-2030）
  • 預配方
  • 配方開發
  • 配方展望（銷售額，2018-2030）
  • 口服
  • 注射
  • 局部藥物
  • 其他
  • 治療領域展望（銷售額，2018-2030）
  • 腫瘤學
  • 感染疾病
  • 神經病學
  • 血液學
  • 呼吸系統
  • 心血管
  • 皮膚科
  • 其他
  • 最終用途展望（銷售額，2018-2030）
  • 製藥和生物製藥公司
  • 政府和學術機構
  • 其他

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國製藥開發外包市場變數、趨勢與範圍

  • 市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析-波特五力分析
    • PESTLE分析

第4章美國製藥開發外包市場：服務分析

  • 2024年及2030年服務市場佔有率
  • 服務細分儀表板
  • 市場規模、預測與趨勢分析（按服務，2018-2030 年）
  • 處方前
  • 配方開發

第5章美國製藥開發外包市場：配方分析

  • 2024年及2030年的醫藥市場佔有率
  • 處方細分細分儀表板
  • 2018 年至 2030 年市場規模、預測與趨勢分析（按配方）
  • 口服
  • 注射
  • 話題
  • 其他

第6章美國治療領域開發外包市場：治療領域分析

  • 2024 年和 2030 年治療領域市場佔有率
  • 治療領域細分儀表板
  • 按治療領域分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 腫瘤學
  • 感染疾病
  • 神經病學
  • 血液學
  • 呼吸系統
  • 心血管系統
  • 皮膚科
  • 其他

第7章美國配方開發外包市場：最終用途分析

  • 2024 年及 2030 年最終用途市場佔有率
  • 最終用途細分儀表板
  • 按最終用途分類的市場規模、預測和趨勢分析（2018-2030 年）
  • 製藥和生物製藥公司
  • 政府和學術機構
  • 其他

第8章 競爭態勢

  • 參與者概覽
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • SGS Societe Generale de Surveillance SA
    • Intertek Group plc
    • Recipharm AB
    • Lonza
    • Charles River Laboratories
    • Eurofins Scientific
    • Element
    • Labcorp
    • Thermo Fisher Scientific Inc
    • Catalent, Inc
Product Code: GVR-4-68040-281-0

Market Size & Trends:

The U.S. formulation development outsourcing market size was estimated at USD 8.87 billion in 2024 and is projected to grow at a CAGR of 8.3% from 2025 to 2030. This growth is driven by increasing demand for innovative pharmaceutical and biotech products, rising R&D costs, and a need for specialized expertise. Outsourcing formulation development is an attractive option for companies looking to streamline their R&D processes, reduce costs, and access a wider range of resources.

The surge in R&D by pharmaceutical and biotechnology firms is a major driver propelling the demand for outsourced formulation development services. Over the past two decades, R&D spending and new drug launches have increased, leading to cost reduction and accelerated processes through outsourcing. This rising demand has prompted contract service providers to expand their capacities, fostering the growth of the U.S. formulation development outsourcing industry. Consequently, these factors substantially contribute to market expansion.

Drug formulation relies heavily on trial-and-error methods to predict optimal formulations, which can be costly, time-consuming, and labor-intensive. To address the need for reducing expenses on new Active Pharmaceutical Ingredients (APIs) and overall healthcare costs in the pharmaceuticals market, it is crucial to estimate preferred formulations. This helps the industry identify efficient drug development approaches. Consequently, the pharmaceutical and biotechnology sector extensively outsources these services to contract manufacturers to streamline costs and processes.

Advancements in technology drive innovations encourage companies to invest in discovering new compounds and developing blockbuster drugs. This leads to an increase in generic manufacturers and a growing pharmaceutical market, driven by unmet needs for various disorders and rising R&D activities for orphan therapies.

U.S. Formulation Development Outsourcing Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. formulation development outsourcing market report based on service, formulation, therapeutic area, and end use:

  • Service Outlook (Revenue, USD Million; 2018 - 2030)
  • Pre-formulation
  • Formulation Development
  • Formulation Outlook (Revenue, USD Million; 2018 - 2030)
  • Oral
  • Injectable
  • Topical
  • Others
  • Therapeutic Area Outlook (Revenue, USD Million; 2018 - 2030)
  • Oncology
  • Infectious Disease
  • Neurology
  • Hematology
  • Respiratory
  • Cardiovascular
  • Dermatology
  • Others
  • End Use Outlook (Revenue, USD Million; 2018 - 2030)
  • Pharmaceutical and Biopharmaceutical Companies
  • Government and Academic Institutes
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Formulation
    • 1.2.3. Therapeutic Area
    • 1.2.4. End Use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. U.S. Formulation Development Outsourcing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. U.S. Formulation Development Outsourcing Market: Service Business Analysis

  • 4.1. Service Market Share, 2024 & 2030
  • 4.2. Service Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Service, 2018 to 2030 (USD Million)
  • 4.4. Pre-formulation
    • 4.4.1. Pre-formulation Market, 2018 - 2030 (USD Million)
  • 4.5. Formulation Development
    • 4.5.1. Formulation Development Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Formulation Development Outsourcing Market: Formulation Business Analysis

  • 5.1. Formulation Market Share, 2024 & 2030
  • 5.2. Formulation Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Formulation, 2018 to 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Formulation Market, 2018 - 2030 (USD Million)
  • 5.5. Injectable
    • 5.5.1. Injectable Formulation Market, 2018 - 2030 (USD Million)
  • 5.6. Topical
    • 5.6.1. Topical Formulation Market, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other Formulation Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Therapeutic Area Development Outsourcing Market: Therapeutic Area Business Analysis

  • 6.1. Therapeutic Area Market Share, 2024 & 2030
  • 6.2. Therapeutic Area Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Therapeutic Area, 2018 to 2030 (USD Million)
  • 6.4. Oncology
    • 6.4.1. Formulation Development Outsourcing Market, for Oncology, 2018 - 2030 (USD Million)
  • 6.5. Infectious Disease
    • 6.5.1. Formulation Development Outsourcing Market, for Infectious Disease, 2018 - 2030 (USD Million)
  • 6.6. Neurology
    • 6.6.1. Formulation Development Outsourcing Market, for Neurology, 2018 - 2030 (USD Million)
  • 6.7. Hematology
    • 6.7.1. Formulation Development Outsourcing Market, for Hematology, 2018 - 2030 (USD Million)
  • 6.8. Respiratory
    • 6.8.1. Formulation Development Outsourcing Market, for Respiratory, 2018 - 2030 (USD Million)
  • 6.9. Cardiovascular
    • 6.9.1. Formulation Development Outsourcing Market, for Cardiovascular, 2018 - 2030 (USD Million)
  • 6.10. Dermatology
    • 6.10.1. Formulation Development Outsourcing Market, for Dermatology, 2018 - 2030 (USD Million)
  • 6.11. Others
    • 6.11.1. Formulation Development Outsourcing Market, for Others, 2018 - 2030 (USD Million)

Chapter 7. U.S. Formulation Development Outsourcing Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Pharmaceutical and Biopharmaceutical Companies
    • 7.4.1. Pharmaceutical and Biopharmaceutical Companies Segment Market, 2018 - 2030 (USD Million)
  • 7.5. Government and Academic Institutes
    • 7.5.1. Government and Academic Institutes Segment Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Segment Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Overview
  • 8.2. Company Market Position Analysis
  • 8.3. Company Categorization
  • 8.4. Strategy Mapping
  • 8.5. Company Profiles/Listing
    • 8.5.1. SGS Societe Generale de Surveillance SA
      • 8.5.1.1. Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. Intertek Group plc
      • 8.5.2.1. Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. Recipharm AB
      • 8.5.3.1. Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. Lonza
      • 8.5.4.1. Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. Charles River Laboratories
      • 8.5.5.1. Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. Eurofins Scientific
      • 8.5.6.1. Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. Element
      • 8.5.7.1. Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Strategic Initiatives
    • 8.5.8. Labcorp
      • 8.5.8.1. Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. Thermo Fisher Scientific Inc
      • 8.5.9.1. Overview
      • 8.5.9.2. Financial Performance
      • 8.5.9.3. Product Benchmarking
      • 8.5.9.4. Strategic Initiatives
    • 8.5.10. Catalent, Inc
      • 8.5.10.1. Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. formulation development outsourcing market, by service, 2018 - 2030 (USD Million)
  • Table 4. U.S. formulation development outsourcing market, by formulation, 2018 - 2030 (USD Million)
  • Table 5. U.S. formulation development outsourcing market, by therapeutic area, 2018 - 2030 (USD Million)
  • Table 6. U.S. formulation development outsourcing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 U.S. formulation development outsourcing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Service outlook (USD Million)
  • Fig. 10 Formulation outlook (USD Million)
  • Fig. 11 Therapeutic area outlook (USD Million)
  • Fig. 12 End use outlook (USD Million)
  • Fig. 13 Competitive landscape
  • Fig. 14 U.S. formulation development outsourcing market dynamics
  • Fig. 15 U.S. formulation development outsourcing market: Porter's five forces analysis
  • Fig. 16 U.S. formulation development outsourcing market: Pestle analysis
  • Fig. 17 U.S. formulation development outsourcing market: Service segment dashboard
  • Fig. 18 U.S. formulation development outsourcing market: Service market share analysis, 2024 & 2030
  • Fig. 19 Pre-formulation market, 2018 - 2030 (USD Million)
  • Fig. 20 Formulation development market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. formulation development outsourcing market: Formulation segment dashboard
  • Fig. 22 U.S. formulation development outsourcing market: Formulation market share analysis, 2024 & 2030
  • Fig. 23 Oral formulation market, 2018 - 2030 (USD Million)
  • Fig. 24 Injectable formulation market, 2018 - 2030 (USD Million)
  • Fig. 25 Topical formulation market, 2018 - 2030 (USD Million)
  • Fig. 26 Other formulation market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. formulation development outsourcing market: Therapeutic area segment dashboard
  • Fig. 28 U.S. formulation development outsourcing market: Therapeutic area market share analysis, 2024 & 2030
  • Fig. 29 Formulation development outsourcing market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 30 Formulation development outsourcing market, for Infectious Disease, 2018 - 2030 (USD Million)
  • Fig. 31 Formulation development outsourcing market, for Neurology 2018 - 2030 (USD Million)
  • Fig. 32 Formulation development outsourcing market, for Hematology, 2018 - 2030 (USD Million)
  • Fig. 33 Formulation development outsourcing market, for Respiratory, 2018 - 2030 (USD Million)
  • Fig. 34 Formulation development outsourcing market, for Cardiovascular 2018 - 2030 (USD Million)
  • Fig. 35 Formulation development outsourcing market, for Dermatology, 2018 - 2030 (USD Million)
  • Fig. 36 Formulation development outsourcing market, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. formulation development outsourcing market: End use segment dashboard
  • Fig. 38 U.S. formulation development outsourcing market: End use market share analysis, 2024 & 2030
  • Fig. 39 Pharmaceutical and biopharmaceutical companies segment market, 2018 - 2030 (USD Million)
  • Fig. 40 Government and academic institutes segment market, 2018 - 2030 (USD Million)
  • Fig. 41 Other segments market, 2018 - 2030 (USD Million)
  • Fig. 42 Company categorization
  • Fig. 43 Company market position analysis
  • Fig. 44 Strategic framework